The Interplay of Sociodemographic Factors on Virologic Suppression Among a U.S. Outpatient HIV Clinic Population

Shacham, Enbal; Nurutdinova, Diana; Onen, Nur; Stamm, Katelin; Overton, E. Turner
April 2010
AIDS Patient Care & STDs;Apr2010, Vol. 24 Issue 4, p229
Academic Journal
Understanding challenges to virologic suppression is essential to optimizing health outcomes among individuals with HIV. This cross-sectional behavioral assessment was conducted among 514 individuals presenting at an urban U.S. HIV clinic between June and September 2007. The majority of the sample was African American and male, with a mean age of 42 years. Most of the sample was receiving highly active antiretroviral therapy (HAART), and the majority of those had suppressed viral loads (HIV viral loads less than 400 copies per milliliter). By logistic regression analyses, African American/other minorities had 2.9 increased odds, those less than high school degree had 2.3 increased odds, those who were receiving ritonavir-boosted protease inhibitor therapy had 1.4 increased odds, and those who had expressed symptoms indicative of depressive disorders had 2.5 increased odds of having unsuppressed viremia as compared to Caucasians, those with more education, receiving non-nucleoside reverse transcriptase inhibitor-based therapy, and who had minimal depressive symptoms, respectively. These findings signify the importance of individualized interventions to enhance virologic suppression, both based on medication choices and individual characteristics.


Related Articles

  • Determinants of knowledge of HIV status in South Africa: results from a population-based HIV survey. Peltzer, Karl; Matseke, Gladys; Mzolo, Thembile; Majaja, Mmapaseka // BMC Public Health;2009, Vol. 9 Issue 1, p1 

    Background: Over 30% of women and men in the South African national HIV household of 2005 indicated that they had previously been tested for HIV (of which 91% were aware of their test results). This paper seeks to describe the associations between socio-demographic, behavioural and social...

  • Temporal trends in presentation for outpatient HIV medical care 2000-2010: implications for short-term mortality. Seal, Paula; Jackson, David; Chamot, Eric; Willig, James; Nevin, Christa; Allison, Jeroan; Raper, James; Kempf, Mirjam; Schumacher, Joseph; Saag, Michael; Mugavero, Michael; Seal, Paula S; Jackson, David A; Willig, James H; Nevin, Christa R; Allison, Jeroan J; Raper, James L; Kempf, Mirjam C; Schumacher, Joseph E; Saag, Michael S // JGIM: Journal of General Internal Medicine;Jul2011, Vol. 26 Issue 7, p745 

    Background: Many newly diagnosed patients present to outpatient care with advanced HIV infection. More timely HIV diagnosis and initiation of care has the potential to improve individual health outcomes and has public health implications.Objective: To assess temporal...

  • Development and Efficacy of an Intervention to Enhance Readiness for Adherence among Adults Who Had Previously Failed HIV Treatment. Enriquez, Maithe; An-Lin Cheng; McKinsey, David S.; Stanford, James // AIDS Patient Care & STDs;Mar2009, Vol. 23 Issue 3, p177 

    This paper outlines the development and initial testing of the READY intervention that was designed to enhance readiness for adherence among adults with a history of nonadherence to HIV treatment. Participants in this study were adults ( n = 28) who ranged in age from 24 to 57: most were male...

  • Amprenavir. Adkins, J.C.; Faulds, D. // Drugs;Jun1998, Vol. 55 Issue 6, p837 

    â–´ Amprenavir is a viral protease inhibitor with specificity for the HIV protease enzyme. The resistance profile of amprenavir appears to differ from that of other protease inhibitors such as saquinavir and indinavir. â–´ Twelve hours after single-dose administration of amprenavir...

  • Lopinavir: A Viewpoint by Robert L. Murphy. Murphy, R.L. // Drugs;Dec2000, Vol. 60 Issue 6, p1380 

    Comments on a study on the use of the HIV-1 protease inhibitor lopinavir in the treatment of HIV-1 infected patients. Difference of lopinavir with other protease inhibitors; Advantage of using lopinavir; Information on the adverse effect of the lopinavir.

  • Modification of the Incidence of Drug-Associated Symmetrical Peripheral Neuropathy by Host and Disease Factors in the HIV Outpatient Study Cohort. Lichtenstein, Kenneth A.; Armon, Carl; Baron, Anna; Moorman, Anne C.; Wood, Kathleen C.; Liolmberg, Scott D. // Clinical Infectious Diseases;1/1/2005, Vol. 40 Issue 1, p148 

    Background. We sought to identify factors associated with the clinical diagnosis of symmetrical peripheral neuropathy (SPN) during the era of highly active antiretroviral therapy (HAART) in a retrospective, longitudinal cohort analysis. Methods. Patients infected with human immuno deficiency...

  • The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa. Long, Lawrence C.; Fox, Matthew P.; Sauls, Celeste; Evans, Denise; Sanne, Ian; Rosen, Sydney B. // PLoS ONE;2/17/2016, Vol. 11 Issue 2, p1 

    Background: While most HIV care is provided on an outpatient basis, hospitals continue to treat serious HIV-related admissions, which is relatively resource-intensive and expensive. This study reports the primary reasons for HIV-related admission at a regional, urban hospital in Johannesburg,...

  • HIV Incidence and Predictors Associated with Retention in a Cohort of Men Who have Sex with Men in Yangzhou, Jiangsu Province, China. Zhihang Peng; Haitao Yang; Jessie Norris; Xin Chen; Xiping Huan; Rongbin Yu; Ning Wang; Hongbing Shen; Feng Chen // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    Background: The study was to investigate the incidence of HIV-1 and related factors, as well as predictors associated with retention in a cohort study among men who have sex with men (MSM) in Yangzhou, Jiangsu Province, China. A carefully designed 12-month prospective cohort study was conducted....

  • Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8). Protopopescu, Camelia; Marcellin, Fabienne; Spire, Bruno; Préau, Marie; Verdon, Renaud; Peyramond, Dominique; Raffi, François; Chêne, Geneviève; Leport, Catherine; Carrieri, Maria-Patrizia; Préau, Marie; Raffi, François; Chêne, Geneviève // Quality of Life Research;May2007, Vol. 16 Issue 4, p577 

    Background: The long-term efficacy of Highly Active Antiretroviral Therapies (HAART) has enlightened the crucial role of health-related quality of life (HRQL) among HIV-infected patients. However, any analysis of such extensive longitudinal data necessitates a suitable handling of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics